Dr. John Mumm explains the Diakine™ platform developed by Deka Biosciences.
{iframe}https://www.linkedin.com/feed/update/urn:li:activity:6933074632195416064/{/iframe}
Deka Biosciences – Daikine Platform Explanation
Dr. John Mumm explains the Diakine™ platform developed by Deka Biosciences.
BioHealth Innovation, Inc. (BHI) is an innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets.
© 2025 BioHealth Innovation.
You have successfully subscribed to the newsletter
There was an error while trying to send your request. Please try again.